US Market Entry & FDA MoCRA Compliance for Fragrance Exporters

The US market is enormous — but its doors are no longer as easy to open as they once were. MoCRA (Modernization of Cosmetics Regulation Act), which came into force at the end of 2022, fundamentally overhauled a regulatory framework that had been loosely structured for decades. Since fragrance is classified as a cosmetic under this system, there are now four core obligations before the FDA (US Food and Drug Administration).

In short: register your facility, list your products, designate a responsible person, and report adverse events. Everything else is a matter of documentation discipline. Just as top notes yield the stage to base notes once they fade, in export the glamour of marketing gives way to regulatory compliance.

If you have already navigated the European side, the logic will feel familiar — there is a conceptual kinship between CPNP (the European cosmetic products notification portal) registration and MoCRA, but the details differ. Do not conflate the two.

Think of MoCRA as resting on four pillars. If one is missing, the roof will not hold.

The process runs through the FDA's online portal. Follow the sequence without skipping steps; the flow below works in practice.

1. Define your roles

   Identify the manufacturer, responsible person, and (if required) US agent. Decide which name will appear on the label.

2. Create an FDA account

   Set up a corporate account to access the FDA's electronic registration system. Ensure all information is in English and complete.

3. Register your facility

   Enter the manufacturing/processing address, contact details, and type of operations. Each facility is assigned a unique registration number.

4. List your products

   For each product, submit the category, trade name, ingredient list (using INCI names), and responsible person details. If there are multiple variants within the same line, bulk listing is possible.

5. Archive your documents

   Retain the safety assessment file, IFRA compliance declaration, and formula records. The FDA may request these.

6. Keep records up to date

   If an address, formula, or responsible person changes, update the registration within the specified timeframe.

Beyond the registration bureaucracy, your product must actually be safe. MoCRA requires "adequate safety substantiation." That starts at your laboratory bench.

Safety is tied to the molecule, not the source. The assumption that "natural means safe" is the most common — and most costly — mistake. Many of the most strictly restricted allergens (citral, eugenol, oakmoss) are found in high concentrations in natural essential oils. Natural bergamot is phototoxic — it can cause pigmentation on skin exposed to sunlight. By contrast, certain pure synthetics (Ambroxan, Iso E Super) are virtually unproblematic from an allergy standpoint. What matters is the molecule and the usage level.

IFRA limits are not based on total fragrance concentration. Avoid the generalisation that "my fragrance oil is safe up to 20%." Limits are set according to the individual substances within the fragrance oil, allergen levels, and product category (leave-on vs. rinse-off). Request the IFRA compliance declaration from your supplier and do not finalise a formula until it has been reviewed against your target category.

If you use MPG at a high proportion (above approximately 2%), it will leave a tacky feel on skin — keep the dose controlled. If you are looking for a true fixative, explore macrocyclic musks, glucose ethers (such as Glucam P-20), or heavy balsams/resins.

Do not build a formula until you clearly understand the difference between a fragrance oil, a perfume oil, and an essential oil; each behaves differently in terms of solubility. If you are starting from scratch, first establish a solid understanding of basic accord principles (accord — a harmonious blend of raw materials), then move on to the export dimension.

Get your house in order first: safety file, IFRA declaration, label, responsible person. Then proceed to registration. A product listed in haste without complete documentation is the greatest risk you can take. The rest is your signature.